WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Ownership - Who owns Kymera Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kymera Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bvf Partners L PDirector2025-06-30115,783$44.00
$5.09MBuy
Baker Bros Advisors LPDirector2025-06-30600,309$44.00
$26.41MBuy
Bvf Partners L PDirector2025-06-3058,780$44.00
$2.59MBuy
Bvf Partners L PDirector2025-06-30142,604$44.00
$6.27MBuy
Baker Bros Advisors LPDirector2025-06-3055,191$44.00
$2.43MBuy
Elena RidloffDirector2025-06-114,500$20.29
$91.31kBuy
Elena RidloffDirector2025-06-114,500$50.00
$225.00kSell
Jeffrey W. AlbersDirector2025-06-036,349$10.34
$65.65kBuy
Elena RidloffDirector2025-06-034,800$47.00
$225.60kSell
Pamela EspositoDirector2025-06-035,000$49.04
$245.19kSell

1 of 4

KYMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYMR insiders and whales buy or sell their stock.

KYMR Shareholders

What type of owners hold Kymera Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Price T Rowe Associates Inc10.29%6,702,450$310.66MInstitution
Avoro Capital Advisors LLC9.92%6,460,000$299.42MInstitution
Baker Bros Advisors LP9.39%6,117,295$283.54MInsider
Wellington Management Group LLP9.21%5,996,873$277.96MInstitution
Baker Bros Advisors LP9.21%5,995,929$277.91MInstitution
Atlas Venture Associates X LP8.85%5,763,012$267.12MInsider
Atlas Venture Fund X LP8.45%5,504,905$255.15MInsider
Vanguard Group Inc8.03%5,231,392$242.48MInstitution
Bvf Inc7.93%5,161,801$239.25MInstitution
Atlas Venture Life Science Advisors LLC7.52%4,896,462$226.95MInstitution

1 of 3

KYMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYMR74.53%25.47%Net BuyingNet Buying
IMVT47.98%52.02%Net BuyingNet Selling
CRNX88.82%11.18%Net BuyingNet Selling
LGND16.92%83.08%Net SellingNet Buying
MLTX72.50%27.50%Net SellingNet Selling
View Top Biotech Stocks

Kymera Therapeutics Stock Ownership FAQ

Who owns Kymera Therapeutics?

Kymera Therapeutics (NASDAQ: KYMR) is owned by 111.81% institutional shareholders, 38.21% Kymera Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Kymera Therapeutics shareholder, owning 6.12M shares representing 9.39% of the company. Baker Bros Advisors LP's Kymera Therapeutics shares are currently valued at $282.50M.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.